Two-hour insulin determination improves the ability of abdominal fat measurement to identify risk for the metabolic syndrome

Diabetes Care

Volumn 26, Issue 6, 2003, Pages 1725-1730

  Ribeiro Filho, Fernando F ^a,b   Faria, Alessandra N ^a   Kohlmann, Narcia E B ^a   Zanella, Maria Teresa ^a   Ferreira, Sandra R G ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL; URIC ACID;

ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; AREA UNDER THE CURVE; ARTICLE; BODY FAT; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMPEDANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; RISK FACTOR; SUBCUTANEOUS FAT;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; BODY MASS INDEX; BRAZIL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VISCERA;

EID: 0041668149     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.6.1725     Document Type: Article

References (32)

1. World Health Organization: Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consulation on Obesity. Geneva, World Health Organization, 1997 (Tech. Rep. Ser., no. 894)
2. Reaven GM. Syndrome X: 6 years later. J Intern Med 736 (Suppl.):13-22, 1994
3. Timar O, Sestier F, Levy E: Metabolic syndrome X: a review. Can J Cardiol 16:779-789, 2000
4. Lamarche B, Lemieux S, Dagenais GR, Depres JP: Visceral obesity and the risk of ischaemic heart disease: insights from the Quebec Cardiovascular Study. Growth Horm IGF Res 8:1-8, 1998
5. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr: Body mass index and mortality in a prospective cohort of US adults. N Engl J Med 341:1097-1105, 1999
6. Anderson PJ, Chan JCN, Chan YL, Tomlinson B, Young RP, Lee KKC, Metrewell C, Cockram CS, Critchley JAJH: Visceral fat and cardiovascular risk factors in Chinese NIDDM patients. Diabetes Care 20:1854-1858, 1997
7. Chen CH, Lin KC, Tsai ST, Chou P: Different association of hypertension and insulin-related metabolic syndrome between men and women in 8437 nondiabetic Chinese. Am J Hypertens 13:846-853, 2000
8. Matsunaga Y: Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabete Metab Rev 13:3-13, 1997
9. Egger G: The case for using waist to hip ratio measurements in routine medical checks. Med J Aust 156:280-285, 1992
10. Vague J: The degree of masculine differentiation of obesity: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric acid calculous disease. Am J Clin Nutr 4:20-34, 1956
11. Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endoc Rev 21:697-738, 2000
12. Despres JP, Lemieux I, Prud'Homme D: Treatment of obesity: need to focus on high risk abdominal obese patients. BMJ 322:716-720, 2001
13. Williams MJ, Hunter GR, Kekes-Szabo T, Trueth MS, Snyder S, Berland L, Blaudeau T: Intra-abdominal adipose tissue cut-points related to elevated cardiovascular risk in women. Int J Obes 20:613-617, 1996
14. Després JP, Lamarche B: Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 6:137-159, 1993
15. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults findings from the third national health and nutrition examination survey. JAMA 287:356-359, 2002
16. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N Engl J Med 346:1393-1403, 2001
17. Amer P: Catecholamine-induced lipolysis in obesity. Int J Obes 23 (Suppl. 1):S10-S13, 1999
18. Frayn KN: Visceral fat and insulin resistance: causative or correlative? Br J Nutr 83 (Suppl. 1):S71-S77, 2000
19. Guo Z, Hensrud DD, Johnson CM, Jensen MD: Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 48:1586-1592, 1999
20. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE: Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46:1579-1585, 1997
21. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ, Tremblay A, Bouchard C: Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834, 1992
22. Harmelen VV, Reynisdottir S, Eriksson P, Thörne A, Hoffstedt J, Lönnqvist F, Arner P: Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47:913-917, 1998
23. European Diabetes Epidemiology Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. Lancet 354:617-621, 1999
24. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow-up study, 1971-1992. JAMA 283:2404-2410, 2000
25. Lennep JERV, Westerveld T, Lennep HWORV, Zwinderman AH, Erkelens DW, Wall EEVD: Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol 20:2408-2413, 2000
26. Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti KGMM: Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 14:200-208, 1997
27. Pyorala M, Miettinen H, Laakso M, Pyorala K: Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study. Diabetes Care 23:1097-1102, 2000
28. Seidell JC, Oosterlee A, Deurenberg P, Hautvast JGAJ, Ruijs JHJ: Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age. Eur J Clin Nutr 42:805-815, 1988
29. Rönnemaa T, Koskenvuo M, Marniemi J, Koivunen T, Sajantila A, Rissanen A, Kaitsaari M, Bouchard C, Kaprio J: Glucose metabolism in identical twins discordant for obesity: the critical role of visceral fat. J Clin Endocrinol Metab 82:383-387, 1997
30. Han TS, Leer EM, Seidell JC, Lean MEJ: Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311:1401-1405, 1995
31. Bray GA, Gray DS: Treatment of obesity: an overview. Diabete Metab Rev 4:653-679, 1988
32. Okosun IS, Tedders SH, Choi S, Dever GEA: Abdominal adiposity values associated with established body mass indexes in white, black and Hispanic Americans: a study from the NHANES III. Int J Obes 24:1279-1285, 2000.